Citadel Advisors - CYCLACEL PHARMACEUTICALS INC ownership

CYCLACEL PHARMACEUTICALS INC's ticker is CYCC and the CUSIP is 23254L405. A total of 15 filers reported holding CYCLACEL PHARMACEUTICALS INC in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Citadel Advisors ownership history of CYCLACEL PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2019$11,0000.0%11,621
-35.9%
0.00%
Q4 2018$11,000
-42.1%
18,124
+34.7%
0.00%
Q2 2018$19,000
-82.4%
13,454
-78.3%
0.00%
Q4 2017$108,00061,9000.00%
Other shareholders
CYCLACEL PHARMACEUTICALS INC shareholders Q1 2019
NameSharesValueWeighting ↓
WEDBUSH SECURITIES INC 21,000$28,0000.00%
AJ WEALTH STRATEGIES, LLC 12,677$17,0000.00%
Virtu Financial LLC 39,613$53,0000.00%
BREWIN DOLPHIN LTD 5,586$7,5410.00%
SIGNET FINANCIAL MANAGEMENT, LLC 23$00.00%
UBS Group AG 2,956$4,0000.00%
D'Orazio & Associates, Inc. 100$00.00%
DIMENSIONAL FUND ADVISORS LP 12,240$17,0000.00%
NORTHERN TRUST CORP 13,399$18,0000.00%
GEODE CAPITAL MANAGEMENT, LLC 21,692$29,0000.00%
View complete list of CYCLACEL PHARMACEUTICALS INC shareholders